India Globalization Capital Inc
Change company Symbol lookup
Select an option...
IGC India Globalization Capital Inc
BOAS BOA Acquisition Corp
NKTR Nektar Therapeutics
BB BlackBerry Ltd
DXCM Dexcom Inc
NUV Nuveen Municipal Value Fund
NBIX Neurocrine Biosciences Inc
TTMI TTM Technologies Inc
LEAS Strategic Asset Leasing Inc
$NY2LORCL ICE Leveraged 2x ORCL Index
Go

Industrials : Trading Companies & Distributors | Small Cap Value
Company profile

India Globalization Capital, Inc. (IGC) is engaged in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment includes the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment includes construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer. It is also focused on developing Naphthalene Monoimide (NMI) lead candidate, IGC-AD1, that targets neuropsychiatric symptoms associated with dementia in Alzheimer’s.

Closing Price
$0.59
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
242,410
0

Company Profile

India Globalization Capital, Inc. (IGC) is engaged in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment includes the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment includes construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer. It is also focused on developing Naphthalene Monoimide (NMI) lead candidate, IGC-AD1, that targets neuropsychiatric symptoms associated with dementia in Alzheimer’s.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
75.56x
Price/Book (MRQ)
1.22x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

July 2022
Current Month
1.1M
Previous Month
1.1M
Percent of Float
2.65%
Days to Cover
1.7174 Days

Share Information

IGC is in a share class of common stock
Float
43.4M
Shares Outstanding
52.5M
Institutions Holding Shares
24
7.88%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Richard K. Prins
  • Ram MukundaPres.
  • Claudia GrimaldiCFO
  • Rohit GoelCAO
  • John E. Lynch

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.